DICHIARA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 95
AS - Asia 13
NA - Nord America 11
Totale 119
Nazione #
IT - Italia 63
IE - Irlanda 17
US - Stati Uniti d'America 11
RU - Federazione Russa 8
SG - Singapore 7
UA - Ucraina 3
ID - Indonesia 2
IR - Iran 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
Totale 119
Città #
Siena 23
Dublin 17
Florence 10
Moscow 8
Turin 7
Singapore 5
Boardman 4
Rome 4
Bari 3
Catania 3
Irpin 3
Birmingham 2
Chicago 2
Tangerang 2
Tehran 2
Amsterdam 1
Brno 1
Cernusco sul Naviglio 1
Forest City 1
Hyderabad 1
Milan 1
Springfield 1
Vientiane 1
Wandsworth 1
Zurich 1
Totale 105
Nome #
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 25
Biostimulants for Sustainable Food Production: Effects of Wood Distillate to Fortify Chickpea Flour for Development of Functional Bakery Products 18
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 12
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation 12
Cytotoxicity profiles and neuroprotective properties of the novel ifenprodil analogues as sigma ligands 12
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, In silico, and biological evaluation 11
Novel N-normetazocine derivatives with opioid Agonist/Sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain 10
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 10
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent Sigma-1 receptor antagonist 9
H2S releasing molecules in pharmaceutical development 8
Novel N-Substituted benzomorphan-based compounds: from MOR-agonist/DOR-antagonist to biased/unbiased MOR agonists 8
Sigma-2 receptor ligands QSAR model dataset 8
Synthesis, computational insights, and evaluation of novel sigma receptors ligands 8
Structural and molecular insight into Piperazine and Piperidine derivatives as Histamine H3 and Sigma-1 receptor antagonists with promising antinociceptive properties 6
Tuning properties for blood-brain barrier permeation: a statistics-based analysis 6
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 6
Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents 6
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties 6
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma 6
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1 6
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase 5
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 5
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 3
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 3
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 3
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 3
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 3
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 3
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 3
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 3
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 3
Repurposing of human kinase inhibitors in neglected protozoan diseases 3
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 3
Totale 236
Categoria #
all - tutte 1.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 0 0 0 0 62 1
2023/2024159 1 0 0 5 0 3 18 2 5 0 18 107
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 236